PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IVZ vs. UL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IVZ and UL is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

IVZ vs. UL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Ltd. (IVZ) and The Unilever Group (UL). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
11.11%
-9.24%
IVZ
UL

Key characteristics

Sharpe Ratio

IVZ:

0.74

UL:

0.86

Sortino Ratio

IVZ:

1.15

UL:

1.33

Omega Ratio

IVZ:

1.15

UL:

1.18

Calmar Ratio

IVZ:

0.43

UL:

0.88

Martin Ratio

IVZ:

3.49

UL:

2.22

Ulcer Index

IVZ:

6.21%

UL:

6.67%

Daily Std Dev

IVZ:

29.31%

UL:

17.22%

Max Drawdown

IVZ:

-83.87%

UL:

-53.55%

Current Drawdown

IVZ:

-32.74%

UL:

-14.49%

Fundamentals

Market Cap

IVZ:

$8.15B

UL:

$137.99B

EPS

IVZ:

$1.18

UL:

$2.40

PE Ratio

IVZ:

15.42

UL:

23.18

PEG Ratio

IVZ:

1.54

UL:

2.81

Total Revenue (TTM)

IVZ:

$4.48B

UL:

$60.76B

Gross Profit (TTM)

IVZ:

$1.72B

UL:

$60.76B

EBITDA (TTM)

IVZ:

$731.90M

UL:

$13.01B

Returns By Period

In the year-to-date period, IVZ achieves a 5.23% return, which is significantly higher than UL's -1.87% return. Over the past 10 years, IVZ has underperformed UL with an annualized return of -3.38%, while UL has yielded a comparatively higher 5.93% annualized return.


IVZ

YTD

5.23%

1M

6.95%

6M

11.11%

1Y

22.93%

5Y*

5.37%

10Y*

-3.38%

UL

YTD

-1.87%

1M

-0.04%

6M

-9.24%

1Y

12.69%

5Y*

1.98%

10Y*

5.93%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IVZ vs. UL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IVZ
The Risk-Adjusted Performance Rank of IVZ is 6666
Overall Rank
The Sharpe Ratio Rank of IVZ is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of IVZ is 6262
Sortino Ratio Rank
The Omega Ratio Rank of IVZ is 6161
Omega Ratio Rank
The Calmar Ratio Rank of IVZ is 6464
Calmar Ratio Rank
The Martin Ratio Rank of IVZ is 7474
Martin Ratio Rank

UL
The Risk-Adjusted Performance Rank of UL is 7070
Overall Rank
The Sharpe Ratio Rank of UL is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of UL is 6767
Sortino Ratio Rank
The Omega Ratio Rank of UL is 6767
Omega Ratio Rank
The Calmar Ratio Rank of UL is 7777
Calmar Ratio Rank
The Martin Ratio Rank of UL is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IVZ vs. UL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Ltd. (IVZ) and The Unilever Group (UL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IVZ, currently valued at 0.74, compared to the broader market-2.000.002.000.740.86
The chart of Sortino ratio for IVZ, currently valued at 1.15, compared to the broader market-4.00-2.000.002.004.006.001.151.33
The chart of Omega ratio for IVZ, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.18
The chart of Calmar ratio for IVZ, currently valued at 0.43, compared to the broader market0.002.004.006.000.430.88
The chart of Martin ratio for IVZ, currently valued at 3.49, compared to the broader market0.0010.0020.0030.003.492.22
IVZ
UL

The current IVZ Sharpe Ratio is 0.74, which is comparable to the UL Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of IVZ and UL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.74
0.86
IVZ
UL

Dividends

IVZ vs. UL - Dividend Comparison

IVZ's dividend yield for the trailing twelve months is around 4.51%, more than UL's 3.35% yield.


TTM20242023202220212020201920182017201620152014
IVZ
Invesco Ltd.
4.51%4.66%4.42%4.08%2.89%4.45%6.84%7.11%3.15%3.66%3.17%2.47%
UL
The Unilever Group
3.35%3.29%3.83%3.61%3.77%3.07%3.17%3.46%2.79%3.40%3.02%3.69%

Drawdowns

IVZ vs. UL - Drawdown Comparison

The maximum IVZ drawdown since its inception was -83.87%, which is greater than UL's maximum drawdown of -53.55%. Use the drawdown chart below to compare losses from any high point for IVZ and UL. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-32.74%
-14.49%
IVZ
UL

Volatility

IVZ vs. UL - Volatility Comparison

Invesco Ltd. (IVZ) has a higher volatility of 11.56% compared to The Unilever Group (UL) at 8.26%. This indicates that IVZ's price experiences larger fluctuations and is considered to be riskier than UL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%SeptemberOctoberNovemberDecember2025February
11.56%
8.26%
IVZ
UL

Financials

IVZ vs. UL - Financials Comparison

This section allows you to compare key financial metrics between Invesco Ltd. and The Unilever Group. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab